PREVALENCE OF INSULIN RESISTANCE IN PREDIABETIC PATIENTS WITH HYPERTENSION

Tran Vinh Thanh 1, Le Thanh Van 1, Doan Sang 2, Duong Linh Ha Khanh 1,, Kieu Dung Ngoc 3, Nguyen Thuc Tri 4
1 Biochemistry Department - Cho Ray Hospital
2 Ophthalmic Diagnostic Imaging Service - Eye Hospital of Ho Chi Minh City
3 Arrhythmias Treatment Department - Cho Ray Hospital
4 Office of the Director - Cho Ray Hospital

Nội dung chính của bài viết

Tóm tắt

stage between normal people and patients with type 2 diabetes mellitus. The pathogenesis is mainly related to insulin resistance (IR). The relationship between IR and hypertension is a complex and multifactorial phenomenon. We examined the prevalence of IR in prediabetic patients with hypertension.


Objectives: The present study aimed to determine the incidence of IR according to the HOMA2 model in the group of prediabetes with hypertension, compared with the group of prediabetes without hypertension.


Subjects and Methods: The cross-sectional study described and collected data from 191 people with prediabetes from February 2023 to September 2023 at the Examination Department of Cho Ray Hospital. IR was determined by the HOMA2 calculator, using a threshold of 1.29 for IR. Prediabetes and hypertension were diagnosed according to ADA 2022 and ISH 2020 criteria, respectively.


Results: The number of subjects selected to analyze the data was 179 patients, including 89 prediabetes patients without hypertension and 90 prediabetes patients with hypertension. The prevalence of IR in the overall prediabetes group was 56.9%. The prevalence of IR in the hypertensive group was 66.7%, higher than the non-hypertensive group at 47.2%, which was statistically significantly different. The values of the index in HOMA2 did not differ statistically significantly between non-hypertensive and hypertensive populations.


Conclusions: The prevalence of IR in prediabetes patients with hypertension was 66.7%, greater than the prediabetes patients without hypertension of 47.2%, P = 0.013. Attention should be paid to good control of blood pressure in patients with prediabetes.

Chi tiết bài viết

Tài liệu tham khảo

1. International Diabetes Federation. IDF Diabetes Atlas. IDF; 2021. https://www.diabetesatlas.org
2. Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol. Jun 2019;234(6):8152-8161. doi:10.1002/jcp.27603
3. Trần Thành Vinh. Nghiên cứu tình trạng kháng insulin trên bệnh nhân tiền đái tháo đường có tăng huyết áp bằng mô hình HOMA2. Bệnh viện Chợ Rẫy; 2023.
4. American Diabetes Association Professional Practice C. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. Jan 1 2022;45(Suppl 1):S17-S38. doi:10.2337/dc22-S002
5. Phạm Hữu Tiến. Nghiên cứu tỉ lệ và yếu tố liên quan tiền đái tháo đường trên bệnh nhân tăng huyết áp tại bệnh viện quận Bình Thạnh năm 2022. Tạp Chí Y học Việt Nam, 515(2). (2022). https://doi.org/10.51298/vmj.v515i2.2817
6. Sakr HF, Sirasanagandla SR, Das S, Bima AI, Elsamanoudy AZ. Insulin Resistance and Hypertension: Mechanisms Involved and Modifying Factors for Effective Glucose Control. Biomedicines. Aug 15 2023;11(8)doi:10.3390/biomedicines11082271
7. Li B, Hou C, Li L, Li M, Gao S. The associations of adipokines with hypertension in youth with cardiometabolic risk and the mediation role of insulin resistance: The BCAMS study. Hypertens Res. Jul 2023;46(7):1673-1683. doi:10.1038/s41440-023-01243-9
8. Alidu H, Dapare PPM, Quaye L, Amidu N, Bani SB, Banyeh M. Insulin Resistance in relation to Hypertension and Dyslipidaemia among Men Clinically Diagnosed with Type 2 Diabetes. Biomed Res Int. 2023;2023:8873226. doi:10.1155/2023/8873226